Food companies Hostess Brands, B&G Foods and Ferrero have placed bids in the first round for the acquisition of Kellogg’s Famous Amos, Keebler, and other snack units.

A deal could potentially be worth more than $1.5bn.

In 2018, Kellogg announced its intention to divest its snack brands, including Mother’s Cookies and the Stretch Island Fruit brand.

Citing people familiar with the matter, CNBC reported that private investment firms are also competing for these units.

Kellogg’s competitor Campbell Soup is also divesting its Australian cookie brand Arnott’s.

Campbell’s cookie brand has attracted bids from Ferrero, Mondelez and Kraft Heinz, CNBC reported.

“Kellogg, Kraft Heinz, General Mills and Campbell are among the major food companies that are slimming down their portfolios to spur growth.”

Kellogg, Kraft Heinz, General Mills and Campbell are among the major food companies that are slimming down their portfolios to spur growth.

In 2018, Heinz announced plans to sell its Indian food business Complan.

These divestments have enabled firms such as Ferrero to widen their market through established brands.

Italy-based Ferrero has been aggressively expanding its presence in the last two years.

In 2017, it bought US-based Ferrara Candy Company, which owns brands such as Red Hots and Now & Later candies, for $1bn. It also acquired Nestle’s US candy business for $2.8bn.

Hostess has been looking to expand its portfolio beyond Twinkies and Ho-Hos.

In February 2018, Hostess executive chairman Dean Metropoulos said that the firm had looked at every snack acquisition announced that year but was discouraged by high valuations.

In 2018, it acquired breakfast brands Big Texas and Cloverhill from Aryzta.

In 2015, B&G acquired Green Giant from General Mills for $765m. In 2018, it bought McCann’s Irish oatmeal from TreeHouse Foods for $32m.

 

Free Whitepaper How electronic inspection sensors prevented a potentially extremely costly product recall

A pharmaceutical client was at risk of a product recall due to a capping problem with a new tablet formulation. This document explains how DJA Pharma prevented a costly recall with a simple, elegant and effective solution.

Enter your details here to receive your free whitepaper.

Machinery whitepaper

Download our whitepaper

Yes I have read and accept the terms and conditions and privacy policys.


You are in control of the communications you receive from us and you can update your preferences anytime to make sure you are receiving information that matters to you. Please check our Verdict Privacy Policy to see how we protect and manage your submitted data.

You will receive your free whitepaper after you submit the form.

Close